You are here

Origin Therapeutics Holdings Inc.

Origin Therapeutics Holdings Inc.
Listing Exchange: 
CSE
Status: 
Active
Industry: 
Diversified Industries
Symbol: 
ORIG
CSE Index: 
Currency: 

Origin Therapeutics Holdings is an actively managed investment issuer focused on making equity investments in psychedelics industry-related companies to provide investors with diverse exposure to the sector. The Company, led by a team of industry experts, leverages its management expertise, professional network, and due diligence process to identify and invest in leading and emerging companies focused on the emerging psychedelics sector. 

You are here

Origin Therapeutics Holdings Inc. (ORIG)

SEDAR Information

Company Info

Address
1570-505 Burrard Street
Vancouver, BC V7X 1M5
Canada
Phone
(604) 416-4099
Email
Klee@k2capital.ca
Website
https://www.originpsychedelics.com
Listing date
Monday, June 6, 2022
Transfer Agent
Olympia Trust Company

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
56,563,000
Reserved for Issuance: 
3,098,700

Company Officers

Alexander Somjen, Chief Executive Officer
Kelvin Lee, Chief Financial Officer and Corporate Secretary
Michael Young, Chairperson

Bulletins

02/06/2022

2022-0604 - New Listing - Origin Therapeutics Holdings Inc. (ORIG)

le juin 2/June 2022

The common shares of Origin Therapeutics Holdings Inc. have been approved for listing on the CSE.

Listing and disclosure documents will be available at www.thecse.com on the trading date.

Advertisement

Publicité

Latest CSE News

Upcoming Events

2022-12-07-Arcview-Access-Cannabis-Investment-Summit_Website.jpg

Arcview Access Cannabis Investment Summit

Wednesday, December 7, 2022 - 7:00pm to Friday, December 9, 2022 - 1:00pm